Slug overexpression is associated with poor prognosis in thymoma patients

Zhang,Tianqiang; Chen,Xu; Chu,Xiumei; Shen,Yi; Jiao,Wenjie; Wei,Yucheng; Qiu,Tong; Yan,Guanzhong; Wang,Xiaofei; Xu,Linhao

doi:10.3892/ol.2015.3851

Slug overexpression is associated with poor prognosis in thymoma patients

Authors:
- Tianqiang Zhang
- Xu Chen
- Xiumei Chu
- Yi Shen
- Wenjie Jiao
- Yucheng Wei
- Tong Qiu
- Guanzhong Yan
- Xiaofei Wang
- Linhao Xu
View Affiliations

Affiliations: Department of Thoracic Surgery, The Affiliated Hospital, Qingdao University, Qingdao, Shandong 266003, P.R. China
Published online on: October 30, 2015 https://doi.org/10.3892/ol.2015.3851
Pages: 306-310

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Slug, a member of the Snail family of transcriptional factors, is a newly identified suppressive transcriptional factor of E‑cadherin. The present study investigated the expression pattern of Slug in thymomas to evaluate its clinical significance. Immunohistochemistry was used to investigate the expression pattern of the Slug protein in archived tissue sections from 100 thymoma and 60 histologically normal thymus tissue samples. The associations between Slug expression and clinicopathological factors, such as prognosis, were analyzed. Positive expression of Slug was detected in a greater proportion of thymoma samples [51/100 (51%) patients, P<0.001] compared with normal thymus tissues [9/60 (15%) cases]. Of the 100 patients with thymoma, 42 (42%) displayed high levels of Slug expression (high‑level group) and 58 (58%) displayed low levels of Slug expression (low‑level group). The 10‑year survival rate was improved for patients in the low‑level group when compared with those in the high‑level group (P=0.002). A multivariate analysis using the Cox proportional hazards regression model demonstrated that Slug overexpression was not an independent prognostic factor. In conclusion, the present study demonstrated that Slug overexpression was associated with poor prognosis in patients with thymoma. Therefore, Slug may be a potential diagnostic biomarker and a predictor of poor prognosis in thymoma patients.

View Figures

View References

1	Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P and Mueller-Hermelink HK: New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer. 95:420–429. 2002. View Article : Google Scholar : PubMed/NCBI
2	Venuta F, Anile M, Diso D, Vitolo D, Rendina EA, De Giacomo T, Francioni F and Coloni GF: Thymoma and thymic carcinoma. Eur J Cardiothorac Surg. 37:13–25. 2010. View Article : Google Scholar : PubMed/NCBI
3	Wright CD: Management of thymomas. Crit Rev Oncol Hematol. 65:109–120. 2008. View Article : Google Scholar : PubMed/NCBI
4	Evoli A, Minisci C, Di Schino C, Marsili F, Punzix C, Batocchi AP, Tonali PA, Doglietto GB, Granone P, Trodella L, et al: Thymoma in patients with MG: Characteristics and long-term outcome. Neurology. 59:1844–1850. 2002. View Article : Google Scholar : PubMed/NCBI
5	Nieto MA, Sargent MG, Wilkinson DG and Cooke J: Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science. 264:835–839. 1994. View Article : Google Scholar : PubMed/NCBI
6	Peinado H, Portillo F and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI
7	Yang HW, Menon LG, Black PM, Carroll RS and Johnson MD: SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer. 10:3012010. View Article : Google Scholar : PubMed/NCBI
8	Vesuna F, van Diest P, Chen JH and Raman V: Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 367:235–241. 2008. View Article : Google Scholar : PubMed/NCBI
9	Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 3:155–166. 2002. View Article : Google Scholar : PubMed/NCBI
10	Shioiri M, Shida T, Koda K, et al: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer. 94:1816–1822. 2006. View Article : Google Scholar : PubMed/NCBI
11	Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S and Aikou T: Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 11:1174–1180. 2005.PubMed/NCBI
12	Hajra KM, Chen DY and Fearon ER: The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62:1613–1618. 2002.PubMed/NCBI
13	Hasan MR, Sharma R, Saraya A, Chattopadhyay≈ TK, Gupta Datta S, Walfish PG, Chauhan SS and Ralhan R: Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients. PLoS One. 8:e828462013. View Article : Google Scholar : PubMed/NCBI
14	Travis WD, Brambilla E, Müller-Hermelin HK and Harris CC: Pathology and Genetics. Tumours of the lung, pleura, thymus and heart. World Health Organisation Classification of Tumors (Lyon). IARC Press. 142–143. 2004.
15	Masaoka A, Monden Y, Nakahara K and Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer. 48:2485–2492. 1981. View Article : Google Scholar : PubMed/NCBI
16	Sugimachi K, Aishima S, Taguchi K, et al: The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol. 35:74–79. 2001. View Article : Google Scholar : PubMed/NCBI
17	Barker N and Clevers H: Tumor environment: A potent driving force in colorectal cancer? Trends Mol Med. 7:535–537. 2001. View Article : Google Scholar : PubMed/NCBI
18	Grünert S, Jechlinger M and Beug H: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003. View Article : Google Scholar : PubMed/NCBI
19	Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
20	Alves CC, Carneiro F, Hoefler H and Becker KF: Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci (Landmark Ed). 14:3035–3050. 2009. View Article : Google Scholar : PubMed/NCBI
21	Hemavathy K, Guru SC, Harris J, Chen JD and Ip YT: Human Slug is a repressor that localizes to sites of active transcription. Mol Cell Biol. 20:5087–5095. 2000. View Article : Google Scholar : PubMed/NCBI
22	Uchikado Y, Okumura H, Ishigami S, et al: Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer. 14:41–49. 2011. View Article : Google Scholar : PubMed/NCBI
23	Hemavathy K, Ashraf SI and Ip YT: Snail/slug family of repressors: Slowly going into the fast lane of development and cancer. Gene. 257:1–12. 2000. View Article : Google Scholar : PubMed/NCBI
24	Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K, Mao M, Inaba T and Look AT: SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell. 4:343–352. 1999. View Article : Google Scholar : PubMed/NCBI
25	Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
26	Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG and Baulida J: Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem. 277:39209–39216. 2002. View Article : Google Scholar : PubMed/NCBI
27	Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
28	Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
29	Grob D, Brunner N, Namba T and Pagala M: Lifetime course of myasthenia gravis. Muscle Nerve. 37:141–149. 2008. View Article : Google Scholar : PubMed/NCBI
30	Vincent A, Willcox N, Hill M, Curnow J, MacLennan C and Beeson D: Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev. 164:157–168. 1998. View Article : Google Scholar : PubMed/NCBI
31	Suzuki S, Nishimoto T, Kohno M, Utsugisawa K, Nagane Y, Kuwana M and Suzuki N: Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis. J Neuroimmunol. 258:61–66. 2013. View Article : Google Scholar : PubMed/NCBI